跳至主要内容
临床试验/NCT07144540
NCT07144540尚未招募不适用

The Effectiveness of NeuroBot in Alleviating Anxiety of Patients Undergoing Neurovascular Surgeries

Chinese University of Hong Kong1 个研究点 分布在 1 个国家目标入组 146 人开始时间: 2025年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
146
试验地点
1
主要终点
Anxiety

研究概览

简要总结

The goal of this randomized controlled trial is to investigate the effectiveness of NeuroBot in alleviating anxiety of patients undergoing neurovascular procedures. The main questions it aims to answer are:

Is NeuroBot effective in alleviating anxiety? Is NeuroBot effective in enhancing patients' procedure and disease-related knowledge? Is NeuroBot effective in enhancing patients' compliance to treatment? If there is a comparison group: Researchers will compare with standard perioperative education (control group) to see if there is any difference in results.

Participants will be invited to chat with the artificial intelligence based chatbot "NeuroBot" for 6 weeks, from the date of preoperative clinic visit till 4 weeks after the surgery. The participants are allowed to access the NeuroBot at anytime anywhere, to ask surgery- related questions at their discretion.

详细描述

The NeuroBot is co-developed by the neurosurgeons, nuerosurgical specialty nurses in Queen Elisabeth Hospital and AI experts from the Hong Kong Polytechnic University and the Chinese University of Hong Kong. The NeuroBot is developed based on the large language model that used machine learning algorithm and generative pretrained transformer model. Vast dataset of neurovascular surgery related information from validated sources, including DynaMed, UpToDate and textbooks were included and used for training of NeuroBot. The precision of the responses generated by NeuroBot was verified by a group of neurosurgical domain experts (neurosurgeons and experienced neurosurgical nurses).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •aged above 18 years;
  • •scheduled for elective neuroendovascular surgery;
  • •able to understand Chinese and read Chinese;
  • •mobile device with internet capability.

排除标准

  • •identified cognitive impairment or have difficulty in understanding study procedures, following instructions, or providing informed consent;
  • •prior exposure to health chatbot to acquire health-related information in previous 3 months;
  • •have neurovascular surgeries before

研究组 & 干预措施

Standard care arm

Active Comparator

The participants will receive standard perioperative care as usual care

干预措施: Standard Care (in control arm) (Other)

NeuroBot arm

Experimental

Patients will receive additional support from NeuroBot during perioperative period

干预措施: NeuroBot (Other)

NeuroBot arm

Experimental

Patients will receive additional support from NeuroBot during perioperative period

干预措施: Standard Care (in control arm) (Other)

结局指标

主要结局

Anxiety

时间窗: From preoperative (at nurse clinic) to postoperative from 1 week to 4 weeks after surgery

Level of preoperative and postoperative anxiety, measured using State Trait Anxiety Inventory - State scale (6-item Chinese version). There are total of 6-item in the questionnaire, each item uses a 1 to 4 point rating scale. 1: not at all; 2: somewhat; 3: moderate; 4: very much so. The higher the score indicates the greater levels of anxiety

次要结局

  • Postoperative complications(4 weeks after surgery)
  • Knowledge(From preoperative nurse clinic visit to 1 week postoperative)
  • Compliance(4 weeks after surgery)
  • Readmission(4 weeks after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

HO Chung Man

Doctor of Nursing Student

Chinese University of Hong Kong

研究点 (1)

Loading locations...

相似试验